Skin Cancer – Research Article

Choi M.E. · Cho H. · Won C.H. · Chang S.E. · Lee M.W. · Lee W.J.

Author affiliations

Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: February 11, 2022
Accepted: June 04, 2022
Published online: July 25, 2022

Number of Print Pages: 9
Number of Figures: 3
Number of Tables: 2

ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)

For additional information: https://www.karger.com/DRM

Abstract

Background: Nail apparatus melanoma (NAM) is a subtype of cutaneous melanoma occurring at nail units and belongs to the acral lentiginous melanoma subgroup. Due to its unique anatomical structure to protect the acral site, mechanical trauma may have a clinicoprognostic impact on NAM. Therefore, we investigated the clinicoprognostic and histopathological characteristics of NAM according to the presence of trauma history prior to melanoma development. Methods: Clinicopathological and follow-up data of patients with NAM according to trauma history were obtained. Results: We included 87 patients with NAM, 21.8% of whom had a previous trauma history. Trauma-related NAMs were more likely to involve the toenail (p = 0.040), include a high proportion of amelanotic melanomas (p = 0.038) as well as nail bed tumor (p = 0.013), and have a longer time interval between the onset of nail change and confirmed diagnosis (p = 0.012). Moreover, survival analysis revealed that trauma-related NAMs more frequently showed progression in general (p = 0.034) and nodal metastasis (p = 0.047) and had worse prognosis in terms of progression-free survival (p = 0.004). Conclusion: In conclusion, NAMs with previous trauma have unique clinicoprognostic characteristics. The specific clinicopathological features of NAMs according to trauma indicate that trauma may play a role in melanoma development.

© 2022 S. Karger AG, Basel

References Huayllani MT, Restrepo DJ, Boczar D, Avila FR, Bagaria SP, Spaulding AC, et al. National comprehensive analysis of characteristics of acral lentiginous melanoma. Anticancer Res. 2020 Jun;40(6):3411–5. Huang K, Fan J, Misra S. Acral lentiginous melanoma: incidence and survival in the United States, 2006–2015, an analysis of the SEER Registry. J Surg Res. 2020 Jul;251:329–39. Elefanti L, Zamuner C, Del Fiore P, Stagni C, Pellegrini S, Dall’Olmo L, et al. The molecular landscape of primary acral melanoma: a multicenter study of the Italian Melanoma Intergroup (IMI). Int J Mol Sci. 2021 Apr 7;22(8):3826. Behbahani S, Malerba S, Samie FH. Acral lentiginous melanoma: clinicopathological characteristics and survival outcomes in the US National Cancer Database 2004–2016. Br J Dermatol. 2020 Nov;183(5):952–4. Lino-Silva LS, Zepeda-Najar C, Salcedo-Hernandez RA, Martinez-Said H. Acral lentiginous melanoma: survival analysis of 715 cases. J Cutan Med Surg. 2019 Jan/Feb;23(1):38–43. Teramoto Y, Keim U, Gesierich A, Schuler G, Fiedler E, Tuting T, et al. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. Br J Dermatol. 2018 Feb;178(2):443–51. Wada M, Ito T, Tsuji G, Nakahara T, Hagihara A, Furue M, et al. Acral lentiginous melanoma versus other melanoma: a single-center analysis in Japan. J Dermatol. 2017 Aug;44(8):932–8. Lino-Silva LS, Dominguez-Rodriguez JA, Aguilar-Romero JM, Martinez-Said H, Salcedo-Hernandez RA, Garcia-Perez L, et al. Melanoma in Mexico: clinicopathologic features in a population with predominance of acral lentiginous subtype. Ann Surg Oncol. 2016 Dec;23(13):4189–94. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of california cancer registry data, 1988–93. Cancer Causes Control. 1997 Mar;8(2):246–52. Basurto-Lozada P, Molina-Aguilar C, Castaneda-Garcia C, Vazquez-Cruz ME, Garcia-Salinas OI, Alvarez-Cano A, et al. Acral lentiginous melanoma: basic facts, biological characteristics and research perspectives of an understudied disease. Pigment Cell Melanoma Res. 2021 Jan;34(1):59–71. Zhang N, Wang L, Zhu GN, Sun DJ, He H, Luan Q, et al. The association between trauma and melanoma in the Chinese population: a retrospective study. J Eur Acad Dermatol Venereol. 2014 May;28(5):597–603. Rangwala S, Hunt C, Modi G, Krishnan B, Orengo I. Amelanotic subungual melanoma after trauma: an unusual clinical presentation. Dermatol Online J. 2011 Jun 15;17(6):8. Troyanova P. The role of trauma in the melanoma formation. J BUON. 2002 Oct–Dec;7(4):347–50. Baba FE, Blumenkranz M. Malignant melanoma at the site of penetrating ocular trauma. Arch Ophthalmol. 1986 Mar;104(3):405–9. Ware JW. Sub-ungual malignant melanoma presenting as sub-acute paronychia following trauma. Hand. 1977 Feb;9(1):49–51. Lee JH, Choi YD, Hwang JH, Shin MH, Yun SJ. Frequency of trauma, physical stress, and occupation in acral melanoma: analysis of 313 acral melanoma patients in Korea. Ann Dermatol. 2021 Jun;33(3):228. Kaskel P, Kind P, Sander S, Peter RU, Krahn G. Trauma and melanoma formation: a true association? Br J Dermatol. 2000 Oct;143(4):749–53. Briggs JC. The role of trauma in the aetiology of malignant melanoma: a review article. Br J Plast Surg. 1984 Oct;37(4):514–6. Jung HJ, Kweon SS, Lee JB, Lee SC, Yun SJ. A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress. JAMA Dermatol. 2013 Nov;149(11):1281. Durbec F, Martin L, Derancourt C, Grange F. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol. 2012 Apr;166(4):727–39. Bormann G, Marsch WC, Haerting J, Helmbold P. Concomitant traumas influence prognosis in melanomas of the nail apparatus. Br J Dermatol. 2006 Jul;155(1):76–80. Fanti PA, Dika E, Misciali C, Vaccari S, Barisani A, Piraccini BM, et al. Nail apparatus melanoma: is trauma a coincidence? Is this peculiar tumor a real acral melanoma? Cutan Ocul Toxicol. 2013 Jun;32(2):150–3. Lea AJ. Malignant melanoma of the skin: the relationship to trauma. Ann R Coll Surg Engl. 1965 Sep;37(3):169–76. Green A, McCredie M, MacKie R, Giles G, Young P, Morton C, et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control. 1999 Feb;10(1):21–5. Rolon PA, Kramarova E, Rolon HI, Khlat M, Parkin DM. Plantar melanoma: a case-control study in Paraguay. Cancer Causes Control. 1997 Nov;8(6):850–6. Holman BN, Van Gulick RJ, Amato CM, MacBeth ML, Davies KD, Aisner DL, et al. Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas. Melanoma Res. 2020 Dec;30(6):562–73. Hofer SO, Molema G, Hermens RA, Wanebo HJ, Reichner JS, Hoekstra HJ, et al. The effect of surgical wounding on tumour development. Eur J Surg Oncol. 1999 Jun;25(3):231–43. Naito H, Ziegler MM, Tsou KC. Rational selection of adjuvant chemotherapy after cytoreduction surgery for murine neuroblastoma. Cancer Res. 1985 Aug;45(8):3554–60. Merkel EA, Gerami P. Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features. Lab Invest. 2017 Jun;97(6):630–5. Diaz A, Puig-Butille JA, Valera A, Munoz C, Costa D, Garcia-Herrera A, et al. TERT and AURKA gene copy number gains enhance the detection of acral lentiginous melanomas by fluorescence in situ hybridization. J Mol Diagn. 2014 Mar;16(2):198–206. Bortolotti P, Faure E, Kipnis E. Inflammasomes in tissue damages and immune disorders after trauma. Front Immunol. 2018;9:1900. Antonio N, Bonnelykke-Behrndtz ML, Ward LC, Collin J, Christensen IJ, Steiniche T, et al. The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J. 2015 Sep 2;34(17):2219–36. Mohrle M, Hafner HM. Is subungual melanoma related to trauma? Dermatology. 2002;204(4):259–61. Harrington P, O’Kelly A, Trail IA, Freemont AJ. Amelanotic subungual melanoma mimicking pyogenic granuloma in the hand. J R Coll Surg Edinb. 2002 Aug;47(4):638–40. Ishii L, Richmond NA, Carstens SJ, Vincek V. An amelanotic nail bed melanoma presenting as persistent onychodystrophy. Dermatol Online J. 2018 Mar 15;24(3). Kim SJ, Park HJ, Lee JY, Cho BK. A case of amelanotic subungual melanoma. Ann Dermatol. 2008 Mar;20(1):26. Ghariani N, Boussofara L, Kenani N, Ghannouchi N, Mebazaa A, Denguezli M, et al. Post traumatic amelanotic subungual melanoma. Dermatol Online J. 2008 Jan 15;14(1):13. Hayes IM, Thompson JF, Quinn MJ. Malignant melanoma of the toenail apparatus. J Am Coll Surg. 1995 May;180(5):583–8. Westphal JR, Van’t Hullenaar R, Peek R, Willems RW, Crickard K, Crickard U, et al. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. Int J Cancer. 2000 Jun 15;86(6):768–76. Hofer SOP, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg. 1998 Apr;133(4):383–9. Article / Publication Details

First-Page Preview

Received: February 11, 2022
Accepted: June 04, 2022
Published online: July 25, 2022

Number of Print Pages: 9
Number of Figures: 3
Number of Tables: 2

ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)

For additional information: https://www.karger.com/DRM

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.